跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
bicyclic peptides
首页
药物
bicyclic peptides
bicyclic peptides
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TFR1)
EP 4244235 A1
申请人: BICYCLETX LTD
优先权: 2020
CN
EP
US
WO
8 件公开
BICYCLIC PEPTIDE OLIGONUCLEOTIDE CONJUGATES
EP 3700537 A4
申请人: SAREPTA THERAPEUTICS INC
优先权: 2017
EP
US
WO
5 件公开
CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS
EP 4532513 A1
申请人: FUNDACION PRIVADA INST DE SALUD GLOBAL BARCELONA
优先权: 2022
CN
EP
US
WO
4 件公开
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
US 10913773 B2
申请人: OHIO STATE INNOVATION FOUNDATION
优先权: 2017
US
4 件公开
Bicyclic peptide ligands specific for binding tin-4
CN 119158034 A
申请人: BICYCLE ENTW GMBH
优先权: 2018
CN
4 件公开
Bicyclic peptidyl inhibitors
US 11339192 B2
申请人: OHIO STATE INNOVATION FOUNDATION
优先权: 2018
US
4 件公开
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS
EP 4731638 A1
申请人: BICYCLETX LTD
优先权: 2023
CN
EP
WO
3 件公开
CN 117529489 A
申请人: BICYCLE ENTW GMBH
优先权: 2021
CN
US 20240108738 A1
申请人: BICYCLE TX LTD
优先权: 2022
US
Compounds of reverse turn mimetics and the use thereof (2)
US 8071764 B2
申请人: CHUNG JAE UK
优先权: 2007
CN
US
3 件公开
NOVEL BICYCLIC PEPTIDES
US 2024117005 A1
申请人: COUNCIL QUEENSLAND INST MEDICAL RES
优先权: 2021
CN
US
3 件公开
Cell penetrating peptides and methods of making and using thereof
US 10815276 B2
申请人: ENTRADA THERAPEUTICS INC
优先权: 2016
US
3 件公开
第 1 / 3 页
上一页
下一页
药物
反馈